Create Account | Sign In: Author or Forum

Search Symptoms

Medical Specialty >> Gynecology

Women Still Want Annual Mammograms

9:00 AM CST. Read article More Gynecology News

JOURNAL UPDATE

Female Physicians’ Spouses More Likely to Work

7:00 PM CST. May explain need for female physicians to make more personal and professional adjustments

MONTHLY JOURNAL SUMMARY

October 2017 Briefing - OBGYN & Women’s Health

November 01, 2017. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.


FEATURED ARTICLES

Robert L. Coleman, MD's avatarRucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

Elizabeth M. Swisher, MD's avatarCharacterization of patients with ovarian carcinoma who respond to the PARP inhibitor rucaparib

Elizabeth M. Swisher, MD. Dr. Elizabeth M. Swisher comments on the implications of new data from the ARIEL2 trial, an ongoing Phase 2 trial of the novel PARP inhibitor rucaparib in relapsed, high-grade serous or endometrioid ovarian cancer. The new results offer an important insight into the genetic mechanisms behind tumor sensitivity…

Dr. Alberto De la Guerra's avatarBevacizumab for breast cancer: FDA grants a stay of execution

Dr. Alberto De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.


MEDICAL FOCUS

Tamer M. Fouad, M.D.'s avatar

Breast cancer

By Tamer M. Fouad, M.D. Breast cancer is a cancer that starts in the cells of the breast. Worldwide, breast cancer is the second most common type of cancer after lung cancer (11.9%…

DISCUSSION

RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

By MrRobin

Great articles. learnt a lot from it.

ANNOUNCEMENTS